nodes	percent_of_prediction	percent_of_DWPC	metapath
Pilocarpine—Hypothermia—Metformin—polycystic ovary syndrome	0.0203	0.0663	CcSEcCtD
Pilocarpine—Body temperature decreased—Metformin—polycystic ovary syndrome	0.0203	0.0663	CcSEcCtD
Pilocarpine—Accidental injury—Metformin—polycystic ovary syndrome	0.0129	0.042	CcSEcCtD
Pilocarpine—Ear pain—Metformin—polycystic ovary syndrome	0.00968	0.0316	CcSEcCtD
Pilocarpine—Injury—Metformin—polycystic ovary syndrome	0.00899	0.0294	CcSEcCtD
Pilocarpine—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00846	0.0277	CcSEcCtD
Pilocarpine—Migraine—Metformin—polycystic ovary syndrome	0.00813	0.0266	CcSEcCtD
Pilocarpine—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00763	0.0249	CcSEcCtD
Pilocarpine—Influenza—Metformin—polycystic ovary syndrome	0.00714	0.0233	CcSEcCtD
Pilocarpine—Pancreatitis—Metformin—polycystic ovary syndrome	0.007	0.0229	CcSEcCtD
Pilocarpine—Angina pectoris—Metformin—polycystic ovary syndrome	0.00695	0.0227	CcSEcCtD
Pilocarpine—Bradycardia—Metformin—polycystic ovary syndrome	0.00582	0.019	CcSEcCtD
Pilocarpine—Rhinitis—Metformin—polycystic ovary syndrome	0.00573	0.0187	CcSEcCtD
Pilocarpine—Hepatitis—Metformin—polycystic ovary syndrome	0.00571	0.0187	CcSEcCtD
Pilocarpine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00568	0.0186	CcSEcCtD
Pilocarpine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00563	0.0184	CcSEcCtD
Pilocarpine—Eye disorder—Metformin—polycystic ovary syndrome	0.00534	0.0175	CcSEcCtD
Pilocarpine—Flushing—Metformin—polycystic ovary syndrome	0.0053	0.0173	CcSEcCtD
Pilocarpine—Chills—Metformin—polycystic ovary syndrome	0.00513	0.0168	CcSEcCtD
Pilocarpine—Flatulence—Metformin—polycystic ovary syndrome	0.0049	0.016	CcSEcCtD
Pilocarpine—Dysgeusia—Metformin—polycystic ovary syndrome	0.00487	0.0159	CcSEcCtD
Pilocarpine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00478	0.0156	CcSEcCtD
Pilocarpine—Vision blurred—Metformin—polycystic ovary syndrome	0.00469	0.0153	CcSEcCtD
Pilocarpine—Tremor—Metformin—polycystic ovary syndrome	0.00466	0.0152	CcSEcCtD
Pilocarpine—Syncope—Metformin—polycystic ovary syndrome	0.00446	0.0146	CcSEcCtD
Pilocarpine—Palpitations—Metformin—polycystic ovary syndrome	0.0044	0.0144	CcSEcCtD
Pilocarpine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00437	0.0143	CcSEcCtD
Pilocarpine—Hypertension—Metformin—polycystic ovary syndrome	0.00429	0.014	CcSEcCtD
Pilocarpine—Chest pain—Metformin—polycystic ovary syndrome	0.00423	0.0138	CcSEcCtD
Pilocarpine—Myalgia—Metformin—polycystic ovary syndrome	0.00423	0.0138	CcSEcCtD
Pilocarpine—Discomfort—Metformin—polycystic ovary syndrome	0.00418	0.0137	CcSEcCtD
Pilocarpine—Oedema—Metformin—polycystic ovary syndrome	0.00406	0.0133	CcSEcCtD
Pilocarpine—Infection—Metformin—polycystic ovary syndrome	0.00403	0.0132	CcSEcCtD
Pilocarpine—Shock—Metformin—polycystic ovary syndrome	0.00399	0.0131	CcSEcCtD
Pilocarpine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00397	0.013	CcSEcCtD
Pilocarpine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00392	0.0128	CcSEcCtD
Pilocarpine—Anorexia—Metformin—polycystic ovary syndrome	0.00387	0.0126	CcSEcCtD
Pilocarpine—Hypotension—Metformin—polycystic ovary syndrome	0.00379	0.0124	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.0037	0.0121	CcSEcCtD
Pilocarpine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00365	0.0119	CcSEcCtD
Pilocarpine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00362	0.0118	CcSEcCtD
Pilocarpine—Somnolence—Metformin—polycystic ovary syndrome	0.00361	0.0118	CcSEcCtD
Pilocarpine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00357	0.0117	CcSEcCtD
Pilocarpine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00353	0.0115	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.0035	0.0115	CcSEcCtD
Pilocarpine—Constipation—Metformin—polycystic ovary syndrome	0.00347	0.0113	CcSEcCtD
Pilocarpine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00335	0.0109	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00332	0.0109	CcSEcCtD
Pilocarpine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00321	0.0105	CcSEcCtD
Pilocarpine—Asthenia—Metformin—polycystic ovary syndrome	0.00291	0.00952	CcSEcCtD
Pilocarpine—Pruritus—Metformin—polycystic ovary syndrome	0.00287	0.00939	CcSEcCtD
Pilocarpine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00278	0.00908	CcSEcCtD
Pilocarpine—Dizziness—Metformin—polycystic ovary syndrome	0.00268	0.00877	CcSEcCtD
Pilocarpine—Vomiting—Metformin—polycystic ovary syndrome	0.00258	0.00844	CcSEcCtD
Pilocarpine—Rash—Metformin—polycystic ovary syndrome	0.00256	0.00837	CcSEcCtD
Pilocarpine—Dermatitis—Metformin—polycystic ovary syndrome	0.00256	0.00836	CcSEcCtD
Pilocarpine—Headache—Metformin—polycystic ovary syndrome	0.00254	0.00831	CcSEcCtD
Pilocarpine—Nausea—Metformin—polycystic ovary syndrome	0.00241	0.00788	CcSEcCtD
Pilocarpine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000258	0.000372	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000258	0.000371	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000257	0.00037	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000254	0.000367	CbGpPWpGaD
Pilocarpine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000254	0.000366	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000254	0.000365	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000251	0.000362	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000249	0.000358	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—LHB—polycystic ovary syndrome	0.000247	0.000355	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—HSD3B2—polycystic ovary syndrome	0.000241	0.000347	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—HMMR—polycystic ovary syndrome	0.000239	0.000344	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000238	0.000342	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000237	0.000341	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000235	0.000338	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—AKR1C1—polycystic ovary syndrome	0.000233	0.000336	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000233	0.000335	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000232	0.000334	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000231	0.000333	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00023	0.000332	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.00023	0.000331	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000229	0.00033	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000229	0.00033	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000228	0.000329	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000228	0.000328	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000227	0.000327	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000223	0.000322	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000223	0.000321	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—RRM2—polycystic ovary syndrome	0.000222	0.000319	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000221	0.000318	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000217	0.000313	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000217	0.000312	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—SULT2A1—polycystic ovary syndrome	0.000215	0.000309	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000215	0.000309	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—YAP1—polycystic ovary syndrome	0.000214	0.000308	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000212	0.000305	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—FST—polycystic ovary syndrome	0.000211	0.000304	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000211	0.000303	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00021	0.000303	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000209	0.000301	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	0.000209	0.000301	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000209	0.000301	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—RRM2—polycystic ovary syndrome	0.000208	0.0003	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000208	0.0003	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—LHB—polycystic ovary syndrome	0.000208	0.000299	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000207	0.000299	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000207	0.000299	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000207	0.000298	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000207	0.000298	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—LHB—polycystic ovary syndrome	0.000206	0.000297	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—NAMPT—polycystic ovary syndrome	0.000205	0.000296	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000204	0.000294	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000203	0.000292	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000203	0.000292	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000202	0.000291	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000201	0.00029	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—YAP1—polycystic ovary syndrome	0.0002	0.000289	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.0002	0.000287	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000197	0.000283	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000196	0.000282	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000195	0.000281	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000195	0.000281	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000195	0.000281	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000194	0.000279	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000193	0.000278	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SCT—polycystic ovary syndrome	0.000193	0.000278	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000193	0.000278	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000193	0.000278	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—NAMPT—polycystic ovary syndrome	0.000193	0.000278	CbGpPWpGaD
Pilocarpine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000192	0.000277	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000192	0.000276	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000191	0.000276	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000191	0.000276	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000191	0.000275	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CYP11A1—polycystic ovary syndrome	0.00019	0.000274	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000189	0.000273	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000189	0.000272	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000189	0.000272	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000185	0.000266	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000184	0.000265	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000182	0.000263	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000182	0.000262	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000181	0.000261	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000181	0.000261	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00018	0.00026	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—AKR1C3—polycystic ovary syndrome	0.00018	0.000259	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00018	0.000259	CbGpPWpGaD
Pilocarpine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000179	0.000258	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000179	0.000258	CbGpPWpGaD
Pilocarpine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000179	0.000258	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000178	0.000256	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000177	0.000256	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CYP17A1—polycystic ovary syndrome	0.000177	0.000255	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000177	0.000255	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	0.000175	0.000252	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000175	0.000252	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	0.000169	0.000243	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000168	0.000242	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000168	0.000242	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000166	0.000239	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000166	0.000239	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000165	0.000238	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000164	0.000236	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000164	0.000236	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000164	0.000236	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—TH—polycystic ovary syndrome	0.000163	0.000235	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	0.000162	0.000234	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	0.00016	0.000231	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—SLC2A4—polycystic ovary syndrome	0.000159	0.000229	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000159	0.000228	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—INSR—polycystic ovary syndrome	0.000158	0.000228	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000157	0.000226	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—TH—polycystic ovary syndrome	0.000153	0.00022	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000151	0.000218	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000151	0.000217	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00015	0.000216	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CYP19A1—polycystic ovary syndrome	0.000149	0.000215	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000149	0.000215	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000149	0.000214	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000149	0.000214	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000148	0.000214	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000148	0.000213	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000147	0.000212	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000146	0.000211	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000146	0.000211	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000145	0.000209	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CYP19A1—polycystic ovary syndrome	0.00014	0.000202	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000137	0.000198	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000137	0.000197	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000137	0.000197	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000136	0.000196	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000136	0.000196	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000135	0.000194	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000135	0.000194	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GNAS—polycystic ovary syndrome	0.000133	0.000192	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000132	0.000189	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000131	0.000189	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.00013	0.000188	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00013	0.000188	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00013	0.000187	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00013	0.000187	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—TH—polycystic ovary syndrome	0.000129	0.000186	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000129	0.000185	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000127	0.000183	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—NCOR1—polycystic ovary syndrome	0.000127	0.000183	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000127	0.000182	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000126	0.000182	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000126	0.000182	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000125	0.000181	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000125	0.000181	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GNAS—polycystic ovary syndrome	0.000125	0.00018	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000125	0.00018	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000124	0.000179	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CYP1A1—polycystic ovary syndrome	0.00012	0.000173	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00012	0.000173	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00012	0.000173	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000119	0.000172	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000119	0.000172	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000119	0.000172	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—NCOR1—polycystic ovary syndrome	0.000119	0.000171	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PRL—polycystic ovary syndrome	0.000119	0.000171	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000119	0.000171	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000118	0.00017	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000118	0.00017	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000118	0.000169	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000115	0.000165	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000114	0.000165	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000113	0.000163	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000113	0.000163	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CYP1A1—polycystic ovary syndrome	0.000113	0.000163	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000113	0.000162	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—MTHFR—polycystic ovary syndrome	0.000112	0.000162	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000112	0.000161	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000111	0.00016	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000106	0.000152	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	0.000105	0.000152	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—MTHFR—polycystic ovary syndrome	0.000105	0.000152	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000105	0.000151	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000104	0.00015	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000103	0.000149	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	0.0001	0.000144	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.98e-05	0.000144	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.95e-05	0.000143	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.85e-05	0.000142	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	9.8e-05	0.000141	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	9.77e-05	0.000141	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	9.67e-05	0.000139	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	9.64e-05	0.000139	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	9.51e-05	0.000137	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	9.42e-05	0.000136	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	9.12e-05	0.000131	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PPARG—polycystic ovary syndrome	9.09e-05	0.000131	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—POMC—polycystic ovary syndrome	8.97e-05	0.000129	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—INS—polycystic ovary syndrome	8.92e-05	0.000128	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	8.86e-05	0.000128	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	8.53e-05	0.000123	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—POMC—polycystic ovary syndrome	8.41e-05	0.000121	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	8.39e-05	0.000121	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	8.39e-05	0.000121	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	8.37e-05	0.000121	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—INS—polycystic ovary syndrome	8.36e-05	0.000121	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	8.28e-05	0.000119	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	8.21e-05	0.000118	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	8.19e-05	0.000118	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	8.13e-05	0.000117	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	8.11e-05	0.000117	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	7.84e-05	0.000113	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	7.53e-05	0.000108	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	7.44e-05	0.000107	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	7.33e-05	0.000106	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	7.3e-05	0.000105	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	7.23e-05	0.000104	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	7.19e-05	0.000104	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	7.09e-05	0.000102	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	7.06e-05	0.000102	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—INS—polycystic ovary syndrome	7.05e-05	0.000102	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	7.03e-05	0.000101	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	7.02e-05	0.000101	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	7.02e-05	0.000101	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	6.99e-05	0.000101	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	6.96e-05	0.0001	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	6.93e-05	9.98e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	6.91e-05	9.96e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	6.79e-05	9.78e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	6.78e-05	9.77e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	6.76e-05	9.75e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	6.76e-05	9.74e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	6.7e-05	9.65e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	6.69e-05	9.64e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.44e-05	9.29e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.42e-05	9.26e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.36e-05	9.17e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.98e-05	8.62e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	5.82e-05	8.38e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	5.47e-05	7.88e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	5.19e-05	7.48e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	5.17e-05	7.45e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	5.12e-05	7.38e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.88e-05	7.04e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	4.65e-05	6.7e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.43e-05	6.39e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.42e-05	6.37e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.41e-05	6.35e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.38e-05	6.3e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	4.11e-05	5.92e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.33e-05	4.8e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.29e-05	4.74e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.27e-05	4.71e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	3.07e-05	4.42e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	3.06e-05	4.4e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	3.03e-05	4.36e-05	CbGpPWpGaD
